Overview

Safety Study of Nebivolol for COPD Patients

Status:
Withdrawn

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Chicago

Collaborator:

Forest Laboratories

Treatments:

Nebivolol